Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risks of Stimulant Use for Attention Deficit Hyperactivity Disorder on the Developing Brain: Primum non nocere

Published:2017-05-01 Issue:9 Volume:56 Page:805-810
ISSN:0009-9228
Container-title:Clinical Pediatrics
language:en
Short-container-title:Clin Pediatr (Phila)

Author:

Stern H. Patrick¹,Lipman Jonathan²³,Andersen Susan L.⁴⁵,Bossaer John B.⁶,Thigpen Jim⁶

Affiliation:

1. Developmental-Behavioral Pediatrician (Retired), Telford, TN, USA

2. Neuroscience Consulting, Inc, Unicoi, TN, USA

3. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA

4. Harvard Medical School, Boston, MA, USA

5. McLean Hospital, Belmont, MA, USA

6. Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN, USA

Publisher

SAGE Publications

Subject

Pediatrics, Perinatology, and Child Health

Link

http://journals.sagepub.com/doi/pdf/10.1177/0009922817706148

Reference62 articles.

1. Attention deficit hyperactivity disorder

2. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study

3. Childhood: a suitable case for treatment?

4. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials

5. Attention deficit hyperactivity disorder

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The scientific integrity of ADHD: A critical examination of the underpinning theoretical constructs;Frontiers in Psychiatry;2022-12-21

2. Mineral-Vitamin Treatment Associated with Remission in Attention-Deficit/Hyperactivity Disorder Symptoms and Related Problems: 1-Year Naturalistic Outcomes of a 10-Week Randomized Placebo-Controlled Trial;Journal of Child and Adolescent Psychopharmacology;2019-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3